This is the seventh special EBMT report on the indications for haematopoietic stem cell
transplantation for haematological diseases, solid tumours and immune disorders. Our aim …

Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with
significant morbidity and mortality. Immune destruction of hemopoietic stem cells plays an …

For over two decades, the EBMT has updated recommendations on indications for
haematopoietic cell transplantation (HCT) practice based on clinical and scientific …

Aplastic Anemia | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH The New England Journal of …

Background Haploidentical donor (HID) hematopoietic stem cell transplantation (HSCT) is
an alternative treatment method for severe aplastic anemia (SAA) patients lacking suitable …

Abstract Treatment of severe aplastic anemia has improved significantly over the past 4
decades. This review will summarize the key areas of progress in the use of allogeneic …

Opinion statement Acquired aplastic anemia (AA) is a rare, life-threatening bone marrow
failure (BMF) disorder that affects patients of all ages and is caused by lymphocyte …

Abstract Treatment options for newly diagnosed aplastic anemia (AA) patient includes
upfront allogeneic hematopoietic stem cell transplant (HSCT) or immunosuppressive …

We compared the efficacy and safety of eltrombopag (ELTR) combined with
immunosuppressive therapy (IST) and IST alone in treatment-naïve children with severe …

Techniques for haploidentical hematopoietic stem cell transplantation (haplo-HSCT) to treat
severe aplastic anemia (SAA) have recently improved, but no protocol has been evaluated …